Ketamine effects on anxiety and fear-related behaviors: Current literature evidence and new findings

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Gabriela P. Silote, Espírito Santo, Universidade de São Paulo – USP
  • ,
  • Sabrina F.S. de Oliveira, Espírito Santo
  • ,
  • Deidiane E. Ribeiro, Department of Biomolecular Sciences, Universidade de São Paulo – USP
  • ,
  • Mayara S. Machado, Espírito Santo
  • ,
  • Roberto Andreatini, Universidade Federal do Parana
  • ,
  • Sâmia R.L. Joca
  • Vanessa Beijamini, Espírito Santo

Ketamine, a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist, presents a rapid and sustained antidepressant effect in clinical and preclinical studies. Regarding ketamine effects on anxiety, there is a widespread discordance among pre-clinical studies. To address this issue, the present study reviewed the literature (electronic database MEDLINE) to summarize the profile of ketamine effects in animal tests of anxiety/fear. We found that ketamine anxiety/fear-related effects may depend on the anxiety paradigm, schedule of ketamine administration and tested species. Moreover, there was no report of ketamine effects in animal tests of fear related to panic disorder (PD). Based on that finding, we evaluated if treatment with ketamine and another NMDA antagonist, MK-801, would induce acute and sustained (24 hours later) anxiolytic and/or panicolytic-like effects in animals exposed to the elevated T-maze (ETM). The ETM evaluates, in the same animal, conflict-evoked and fear behaviors, which are related, respectively, to generalized anxiety disorder and PD. Male Wistar rats were systemically treated with racemic ketamine (10, 30 and 80 mg/kg) or MK-801 (0.05 and 0.1 mg/kg) and tested in the ETM in the same day or 24 hours after their administration. Ketamine did not affect the behavioral tasks performed in the ETM acutely or 24 h later. MK-801 impaired inhibitory avoidance in the ETM only at 45 min post-injection, suggesting a rapid but not sustained anxiolytic-like effect. Altogether our results suggest that ketamine might have mixed effects in anxiety tests while it does not affect panic-related behaviors.

Original languageEnglish
Article number109878
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Publication statusPublished - 8 Jun 2020

    Research areas

  • Animal models, Anxiety, Fear, Ketamine, MK-801, Panic

See relations at Aarhus University Citationformats

ID: 178737387